Bioline Diagnostics

Established in 2017, Bioline Diagnostics LLP is committed to advancing healthcare through reliable and innovative diagnostic solutions. With a strong belief that accurate and timely diagnosis is the foundation of effective treatment, we operate with our guiding principle: “Your Safety, Our Commitment.”

Our portfolio spans a wide range of diagnostic offerings, including Immunochromatographic Rapid Tests, Biochemistry Reagents, Point-of-Care Testing (POCT) solutions, and advanced diagnostic instruments such as Hematology Analyzers, Biochemistry Analyzers, and Nephelometry systems. Designed for precision and efficiency, our products support healthcare professionals in delivering dependable patient care.

Under our trusted brands “FirstView” and “TriView”, we continue to strengthen our mission of early, accurate, and accessible diagnosis. These brands symbolize our focus on quality, reliability, and performance across diverse healthcare settings.

With a robust manufacturing capacity of approximately 100,000 tests per day, we ensure a consistent, scalable, and timely supply to meet the growing demands of the healthcare sector.